Junhemeng Biopharmaceutical
A recombinant protein drug developer.
Launch date
Employees
Market cap
-
Enterprise valuation
$110—165m (Dealroom.co estimates Sep 2024.)
小营街道 Zhejiang (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY100m | Series B | |
* | CNY200m | Series B | |
| Total Funding | $41.3m | ||